Investing.com - Financial Markets Worldwide

Longevity Health stock soars after merger with THPlasma in all-stock deal

Published 15/07/2025, 13:16
© Reuters.
XAGE
-5.81%

Investing.com -- Longevity Health Holdings Inc. (NASDAQ:XAGE) stock soared 155% after the company announced a definitive merger agreement with True Health Inc., operator of THPlasma, in an all-stock transaction.

The merger with THPlasma follows Longevity’s acquisition of Carmell Therapeutics in July 2023 and Elevai Skincare in January 2025, further expanding the company’s portfolio in the health and longevity sector. THPlasma operates in the plasma collection industry, addressing the shortfall in plasma and plasma-derived therapeutics in the United States.

Under the terms of the agreement, THPlasma is valued at $59 million plus a $20 million earnout tied to financial performance. The valuation represents 2.5 times THPlasma’s estimated FY26 revenue including the earnout. Longevity stock was valued at $3.00 for the transaction, a 12% premium to the July 11 closing price.

THPlasma is expanding its operations from two centers in New Jersey during FY24 to five centers across New Jersey and Pennsylvania in FY25. The company has secured guaranteed sales offtake agreements worth $100 million in annual sales and achieved cash profitability in FY2024.

For FY2025, THPlasma projects revenue of $10 million, EBITDA of $2 million, and net income of $1 million. The company forecasts substantial growth in FY2026, with revenue expected to reach $32 million (220% YoY), EBITDA of $7 million (250% YoY), and net income of $4 million (325% YoY).

Following the closing, expected in the fourth quarter of 2025, the combined company will continue trading on Nasdaq under the symbol "XAGE." Rajiv Shukla, current Chairman and CEO of Longevity, will serve as Executive Chairman, while George Chi, Founder and CEO of THPlasma, will become Co-Chairman and CEO.

Longevity also announced the mutual termination of its previously planned 20/20 BioLabs transaction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.